The US and EU finalized a trade deal, revealing details on tariffs for pharmaceuticals and semiconductors. A 15% blanket tariff on EU exports to the US was agreed upon, alongside a €750 billion EU commitment to purchase US energy and €600 billion in US investment. While the EU will eliminate tariffs on US industrial goods, concerns remain about the deal's balance. Pharmaceutical tariffs are capped at 15%, and the US will apply its MFN drug pricing policy only to generics. The agreement does not alter the EU's digital services act.

Prepared by Christopher Adams and reviewed by editorial team.